Discussion on Anticoagulation Optimization After Left Atrial Appendage Occlusion
Left atrial appendage (LAA) occlusion has emerged as a non-valvular atrial fibrillation (AF) stroke prevention strategy in recent years. Similar to other congenital heart defect occlusion procedures, patients undergoing LAA occlusion require anticoagulation therapy to prevent device-related thrombus (DRT) events. However, the anticoagulation strategies post-LAA occlusion in China are not yet fully standardized, and clinicians … Read more